102 related articles for article (PubMed ID: 12433048)
1. Preparation of 99mTc labeled substance P (SP).
Ozker SK; Hellman RS; Krasnow AZ
Appl Radiat Isot; 2002 Nov; 57(5):729-32. PubMed ID: 12433048
[TBL] [Abstract][Full Text] [Related]
2. Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with
Majkowska-Pilip A; Koźmiński P; Wawrzynowska A; Budlewski T; Kostkiewicz B; Gniazdowska E
Molecules; 2018 Oct; 23(10):. PubMed ID: 30301182
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Arg1]substance P.
Breeman WA; VanHagen MP; Visser-Wisselaar HA; van der Pluijm ME; Koper JW; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Hazenberg MP; Lamberts SW; Visser TJ; Krenning EP
J Nucl Med; 1996 Jan; 37(1):108-17. PubMed ID: 8543978
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents.
Langer M; La Bella R; Garcia-Garayoa E; Beck-Sickinger AG
Bioconjug Chem; 2001; 12(6):1028-34. PubMed ID: 11716696
[TBL] [Abstract][Full Text] [Related]
5. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
[TBL] [Abstract][Full Text] [Related]
6. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
7. Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues.
García Garayoa E; Rüegg D; Bläuenstein P; Zwimpfer M; Khan IU; Maes V; Blanc A; Beck-Sickinger AG; Tourwé DA; Schubiger PA
Nucl Med Biol; 2007 Jan; 34(1):17-28. PubMed ID: 17210458
[TBL] [Abstract][Full Text] [Related]
8. Sandostatin labeled with 99mTc: in vitro stability, in vivo validity and comparison with 111In-DTPA-octreotide.
Kolan H; Li J; Thakur ML
Pept Res; 1996; 9(3):144-50. PubMed ID: 8875594
[TBL] [Abstract][Full Text] [Related]
9. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro and in vivo evaluation of technetium-99m-labeled folate and methotrexate conjugates as tumor imaging agents.
Okarvi SM; Jammaz IA
Cancer Biother Radiopharm; 2006 Feb; 21(1):49-60. PubMed ID: 16480331
[TBL] [Abstract][Full Text] [Related]
11. Interaction of tachykinins with their receptors studied with cyclic analogues of substance P and neurokinin B.
Ploux O; Lavielle S; Chassaing G; Julien S; Marquet A; d'Orléans-Juste P; Dion S; Regoli D; Beaujouan JC; Bergström L
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8095-9. PubMed ID: 2446317
[TBL] [Abstract][Full Text] [Related]
12. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
Figini M; Emanueli C; Bertrand C; Sicuteri R; Regoli D; Geppetti P
Br J Pharmacol; 1997 Jun; 121(4):773-81. PubMed ID: 9208147
[TBL] [Abstract][Full Text] [Related]
14. High affinity binding of [3H]propionyl-[Met(O2)11]substance P(7-11), a tritiated septide-like peptide, in Chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands.
Sagan S; Beaujouan JC; Torrens Y; Saffroy M; Chassaing G; Glowinski J; Lavielle S
Mol Pharmacol; 1997 Jul; 52(1):120-7. PubMed ID: 9224821
[TBL] [Abstract][Full Text] [Related]
15. Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P.
Smilkov K; Janevik E; Guerrini R; Pasquali M; Boschi A; Uccelli L; Di Domenico G; Duatti A
Appl Radiat Isot; 2014 Sep; 92():25-31. PubMed ID: 24973465
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues.
Baidoo KE; Lin KS; Zhan Y; Finley P; Scheffel U; Wagner HN
Bioconjug Chem; 1998; 9(2):218-25. PubMed ID: 9548537
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
18. Typical and atypical NK1 tachykinin receptor characteristics in the rabbit isolated iris sphincter.
Hall JM; Mitchell D; Morton IK
Br J Pharmacol; 1994 Jul; 112(3):985-91. PubMed ID: 7522864
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-Labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistribution.
Mitra A; Nan A; Ghandehari H; McNeill E; Mulholland J; Line BR
Pharm Res; 2004 Jul; 21(7):1153-9. PubMed ID: 15290854
[TBL] [Abstract][Full Text] [Related]
20. Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain.
Zhuang ZP; Kung MP; Hou C; Ploessl K; Kung HF
Nucl Med Biol; 2005 Feb; 32(2):171-84. PubMed ID: 15721763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]